NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CureDuchenne Ventures

CureDuchenne Ventures

Newport Beach, Californiacureduchenne.org

Overview

CureDuchenne Ventures, LLC is the investment arm of CureDuchenne, a national nonprofit dedicated to curing Duchenne muscular dystrophy, the most common and lethal form of muscular dystrophy . CureDuchenne Ventures supports Duchenne research by using philanthropic donations to encourage development of new Duchenne drugs and provides both grant funding to academic groups, as well as equity financing to biotech and pharmaceutical companies .

Year Founded

2014

Portfolio Companies

11

Investments

CureDuchenne Ventures investments
CompanyDateStageLead
Sonotherapeutics Inc.Jun 2026Series BCo-investor
SonoTheraJun 2026Series BCo-investor
Tevard BiosciencesMay 2026VC RoundCo-investor
Myosana TherapeuticsNov 2025CrowdfundingCo-investor
Entos PharmaceuticalsMay 2025VC RoundLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNewport Beach, California
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.